切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2020, Vol. 06 ›› Issue (01) : 96 -99. doi: 10.3877/cma.j.issn.2096-1537.2020.029

所属专题: 文献

综述

体外膜肺氧合对重度急性呼吸窘迫综合征患者远期预后的影响
张俊谊1, 刘玲1,()   
  1. 1. 210009 南京,东南大学附属中大医院重症医学科
  • 收稿日期:2018-12-20 出版日期:2020-02-28
  • 通信作者: 刘玲
  • 基金资助:
    国家自然科学基金项目(81670074, 81870066); 江苏省自然科学基金项目(BK20181271); 江苏省医学重点学科项目(ZDXKA2016025); 江苏省青年医学人才项目(QNRC2016807); 江苏省第五期"333高层次人才培养工程"第三层次人才项目(LGY2016251)

Long-term outcome of patients with severe ARDS receiving ECMO therapy

Junyi Zhang1, Ling Liu1,()   

  1. 1. Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China
  • Received:2018-12-20 Published:2020-02-28
  • Corresponding author: Ling Liu
  • About author:
    Corresponding author: Liu Ling, Email:
引用本文:

张俊谊, 刘玲. 体外膜肺氧合对重度急性呼吸窘迫综合征患者远期预后的影响[J/OL]. 中华重症医学电子杂志, 2020, 06(01): 96-99.

Junyi Zhang, Ling Liu. Long-term outcome of patients with severe ARDS receiving ECMO therapy[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2020, 06(01): 96-99.

体外膜肺氧合(ECMO)治疗改善重度急性呼吸窘迫综合征(ARDS)患者的生存,但存活的患者仍面临远期存活率低、生存质量不佳等问题,主要表现为身体功能下降、精神障碍、社会特征改变等。深入了解ECMO患者远期预后及其相关影响因素,有助于指导优化ECMO治疗及改善ECMO患者的远期预后。

ECMO improves the survival of patients with severe ARDS. However, survivors still face problems such as decreased long-term survival and poor quality of life, mainly due to the decline of physical function, mental disorders, the transformation of social characteristics, etc.Understanding the long-term outcome of ECMO patients and related risk factors can help guide the treatment of ECMO and improve the long-term outcome of ECMO patients.

1
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J]. JAMA, 2016, 315(8): 788-800.
2
Wallace DJ, Milbrandt EB, Boujoukos A. Hail, CESAR, those who are about to die salute you! [J]. Crit Care, 2010, 14(2): 308.
3
Hodgson CL, Hayes K, Everard T, et al. Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia [J]. Crit Care, 2012, 16(5): R202.
4
Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome [J]. N Engl J Med, 2011, 364(14): 1293-1304.
5
Enger TB, Philipp A, Lubnow M, et al. Long-term survival in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation [J]. Crit Care Med, 2017, 45(10): 1718-1725.
6
von Bahr V, Hultman J, Eksborg S, et al. Long-term survival in adults treated with extracorporeal membrane oxygenation for respiratory failure and sepsis [J]. Crit Care Med, 2017, 45(2): 164-170.
7
Wang ZY, Li T, Wang CT, et al. Assessment of 1-year outcomes in survivors of severe acute respiratory distress syndrome receiving extracorporeal membrane oxygenation or mechanical ventilation: A prospective observational study [J]. Chin Med J (Engl), 2017, 130(10): 1161-1168.
8
Chiumello D, Coppola S, Froio S, et al. What's next after ARDS: Long-term outcomes [J]. Respir Care, 2016, 61(5): 689-699.
9
Schmidt M, Schellongowski P, Patroniti N, et al. Six-month outcome of immunocompromised severe ARDS patients rescued by ECMO [J]. Am J Respir Crit Care Med. 2018. doi: 10.1164/rccm.201708-1761OC.
10
Combes A, Bréchot N, Luyt CE, et al. Extracorporeal membrane oxygenation: beyond rescue therapy for acute respiratory distress syndrome? [J]. Curr Opin Crit Care, 2017, 23(1): 60-65.
11
Lindén VB, Lidegran MK, Frisén G, et al. ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life [J]. Acta Anaesthesiol Scand, 2009, 53(4): 489-495.
12
Orme J Jr, Romney JS, Hopkins RO, et al. Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome [J]. Am J Respir Crit Care Med, 2003, 167(5): 690-694.
13
Schmidt M, Zogheib E, Rozé H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome [J]. Intensive Care Med, 2013, 39(10): 1704-1713.
14
Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial [J]. Lancet, 2009, 374(9698): 1351-1363.
15
Burtin C, Clerckx B, Robbeets C, et al. Early exercise in critically ill patients enhances short-term functional recovery [J]. Crit Care Med, 2009, 37(9): 378-379.
16
Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial [J]. Lancet, 2009, 373(9678): 1874-1882.
17
Huesch MD, Foy A, Brehm C. Survival outcomes following the use of extracorporeal membrane oxygenation as a rescue technology in critically ill patients: Results from pennsylvania 2007-2015 [J]. Crit Care Med, 2018, 46(1): e87-e90.
18
Girard TD, Thompson JL, Pandharipande PP, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study [J]. Lancet Respir Med, 2018, 6(3): 213-222.
19
von Bahr V, Kalzén H, Hultman J, et al. Long-term cognitive outcome and brain imaging in adults after extracorporeal membrane oxygenation [J]. Crit Care Med, 2018, 46(5): e351-e358.
20
Tramm R, Ilic D, Murphy K, et al. A qualitative exploration of acute care and psychological distress experiences of ECMO survivors [J]. Heart Lung, 2016, 45(3): 220-226.
21
Kahn JM, Le T, Angus DC, et al. The epidemiology of chronic critical illness in the United States [J]. Crit Care Med, 2015, 43(2): 282-287.
22
Tramm R, Hodgson C, Ilic D, et al. Identification and prevalence of PTSD risk factors in ECMO patients: A single centre study [J]. Aust Crit Care, 2015, 28(1): 31-36.
23
André-Obadia N, Parain D, Szurhaj W. Continuous EEG monitoring in adults in the intensive care unit (ICU) [J]. Neurophysiol Clin, 2015, 45(1): 39-46.
24
Hollmann W, Strüder HK. Brain function, mind, mood, nutrition, and physical exercise [J]. Nutrition, 2000, 16(7-8): 516-519.
[1] 陈翠萍, 李佩君, 杜景榕, 谢青梅, 许一宁, 卓姝妤, 李晓芳. 互联网联合上门护理在老年全髋关节置换术后的应用效果[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 676-681.
[2] 张秋阳, 余韶芸, 潘向滢, 金家佳, 夏桦, 赵雪红. 成年体外膜肺氧合患者出血影响因素的Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 392-398.
[3] 霍枫, 李智霞, 季茹, 谭晓宇, 范晓礼, 叶啟发. 以循环标准判定死亡的遗体器官捐献分类标准、实施流程及需要注意的问题[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 213-221.
[4] 刘欣茹, 杜鹃, 代健健, 辛秀娟, 高梨梨. SBAR沟通模式在急诊腹股沟疝手术患者中的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 451-455.
[5] 沈琪乐, 赵勤华, 宫素岗, 刘锦铭, 王岚, 邱宏玲. COPD 稳定期患者血清CC16 蛋白表达与肺功能、肺气肿表型的关系分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 690-695.
[6] 杨莎莎, 张毛为, 孙宜田, 刘亚南, 位娟, 魏建, 陈碧. 结缔组织疾病相关间质性肺病并发小气道功能障碍临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 738-743.
[7] 郭璟琪, 魏明言, 刘芳, 李冬凌, 关金平, 李立华. 乙酰半胱氨酸治疗慢性阻塞性肺疾病急性加重期的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 768-772.
[8] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[9] 张璇, 高杨, 房雅君, 姚艳玲. 保护性机械通气在肺癌胸腔镜肺段切除术中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 563-567.
[10] 马锦芳, 何正光, 郑劲平. 盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病黏痰症患者的疗效和安全性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 568-574.
[11] 陈冬丽, 邓迎丽, 毕婧. α-干扰素治疗急性呼吸道病毒感染对Th1/Th2平衡及肺功能的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 590-594.
[12] 陈先志, 许磊, 冯其柱, 王琦. 布地奈德联合复方异丙托溴铵雾化吸入在老年患者腹腔镜围手术期中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 531-536.
[13] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[14] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[15] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?